# Varenicline vs Placebo for the Treatment of Methamphetamine Dependence

> **NCT01011829** · PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 20 (actual)

## Conditions studied

- Methamphetamine Dependence
- Substance Abuse
- Methamphetamine Abuse

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01011829
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011829, "Varenicline vs Placebo for the Treatment of Methamphetamine Dependence". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01011829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*